Dr. Chang is Assistant Professor, Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tenn. He has received a research grant from Amgen and Cytogen, and is on the Speaker's Bureaus of Novartis and Sanofi.
Cost considerations in the management of bladder cancer
"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.
ARCHER trial opens enrollment to assess shorter duration of radiation therapy for MIBC
FDA grants fast track designation to HLD-0915 in mCRPC
What should the adult urologist know about pediatric urologic cancers?
FDA grants de novo authorization to ArteraAI Prostate